| Literature DB >> 32235382 |
Hanfang Zeng1, Yumeng Xi2, Yeqing Li1, Zedong Wang1, Lin Zhang1, Zhaoyu Han1.
Abstract
Entities:
Year: 2020 PMID: 32235382 PMCID: PMC7222412 DOI: 10.3390/ani10040574
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Characteristics of the Holstein dairy cows used in the study.
| Parameter | CON | Treatment I | Treatment II | |
|---|---|---|---|---|
| Number of cows | 10 | 10 | 10 | |
| Parity | 1.88 ± 0.83 | 2.00 ± 0.75 | 1.75 ± 0.89 | 0.83 |
| Lactation days(d) | 211.25 ± 43.21 | 217.00 ± 44.28 | 195.25 ± 59.10 | 0.42 |
| Mike yield (kg/d) | 34.62 ± 4.78 | 34.62 ± 5.62 | 34.62 ± 4.07 | 1.00 |
Note: CON, control group; Treatment I, 30 mL/d APS injection; Treatment II, 50 mL/d APS injection.
Composition and nutrient levels of basal diet of dairy cows (DM basis) %.
| Item | Content(%) | Item | Content |
|---|---|---|---|
| Silage corn | 17.47 | Nutrient levels (2) | |
| Alfalfa grass | 20.66 | DM (%) | 57.10 |
| Corn flour | 21.01 | ME (MJ/kg) | 11.16 |
| Cardamom | 8.00 | NEL (MJ/kg) | 7.20 |
| Oatgrass | 5.02 | CP (%DM) | 17.40 |
| Wet brewer’s grains | 4.53 | NDF (%) | 30.85 |
| Beet pulp | 5.13 | ADF (%) | 19.59 |
| Cottonseed | 4.68 | EE (%) | 5.56 |
| Rapeseed meal | 1.20 | Ash (%) | 7.73 |
| Puffed soybean | 3.95 | Ca (%) | 0.65 |
| Tablet corn | 2.40 | P (%) | 0.45 |
| DDGS | 2.43 | ||
| Premix (1) | 1.05 | ||
| Fatty acid calcium | 0.43 | ||
| Calcium hydrogen phosphate | 0.50 | ||
| Baking soda | 0.74 | ||
| Salt | 0.50 | ||
| MgO | 0.30 | ||
| Total | 100.00 |
(1) The premix provided the following per kg of diets: VA 5 130 IU, VD3 1 283 IU, VE 26 mg, biotin 0.05 mg, β-carotene 0.10 mg, Mn 12 mg, P 12 mg, S 0.85 mg, Zn 64 mg, Se 0.4 mg, Co 0.19 mg. (2) Nutrient levels.
Figure 1Environmental temperature, relative humidity and temperature and humidity index of cowshed. (A): Temperature, (B): Relative humidity, (C): Temperature and humidity index.
Rectal temperature and respiratory rate of dairy cows.
| Item | Time(d) | Groups | ||
|---|---|---|---|---|
| CON | Treatment Ⅰ | Treatment Ⅱ | ||
| Rectal temperature | 0 | 38.74 ± 0.08 | 38.89 ± 0.06 | 38.74 ± 0.08 |
| 4 | 39.11 ± 0.15 | 38.73 ± 0.08 | 38.80 ± 0.07 | |
| 7 | 39.35 ± 0.11 | 39.04 ± 0.06 | 39.12 ± 0.09 | |
| 11 | 39.25 ± 0.09 | 39.10 ± 0.13 | 38.76 ± 0.07 | |
| 14 | 39.43 ± 0.10 | 39.10 ± 0.04 | 39.08 ± 0.07 | |
| 18 | 39.28 ± 0.08 | 39.16 ± 0.06 | 38.88 ± 0.08 | |
| 21 | 39.44 ± 0.13 | 38.85 ± 0.06 | 38.70 ± 0.06 | |
| Respiratory rate | 0 | 47.75 ± 2.18 | 38.87 ± 1.78 | 32.38 ± 1.93 |
| 4 | 57.50 ± 4.14 | 53.50 ± 3.54 | 39.25 ± 3.69 | |
| 7 | 49.88 ± 3.80 | 47.00 ± 6.15 | 45.50 ± 5.72 | |
| 11 | 53.50 ± 3.62 | 45.75 ± 3.03 | 38.00 ± 5.01 | |
| 14 | 62.00 ± 8.23 | 55.75 ± 3.92 | 37.25 ± 3.54 | |
| 18 | 61.25 ± 3.71 | 48.75 ± 7.77 | 49.25 ± 3.37 | |
| 21 | 61.25 ± 5.25 | 48.75 ± 2.75 | 47.50 ± 5.14 | |
Effects of astragalus polysaccharides on serum hormone and HSP70 of heat-stressed dairy cows.
| Item | Groups | Time (d) | Holistic Analysis (Huynh-Feldt) | Concentration (F, P) | Time (F, P) | Interaction (F, P) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 4 | 7 | 11 | 14 | 18 | 21 | ||||||
| INS/(μIU/L) | CON | 20.24 ± 2.57 | 17.20 ± 2.69 | 17.14 ± 3.11 | 17.93 ± 2.75 | 15.43 ± 2.90 | 16.26 ± 2.73 | 15.85 ± 3.28 | 1.000 | 0.416, 0.670 | 0.199, 0.950 | 1.102, 0.446 |
| Treatment Ⅰ | 17.87 ± 4.90 | 14.31 ± 1.77 | 14.38 ± 3.06 | 14.16 ± 1.97 | 16.35 ± 3.61 | 15.04 ± 3.17 | 18.84 ± 4.03 | |||||
| Treatment Ⅱ | 17.09 ± 3.31 | 16.84 ± 2.87 | 18.35 ± 1.53 | 18.49 ± 3.53 | 21.31 ± 3.19 | 16.29 ± 2.50 | 17.39 ± 1.40 | |||||
| 0.321 | 0.697 | 0.856 | 0.529 | 0.621 | 0.492 | 0.492 | ||||||
| GC/(pg/mL) | CON | 96.06 ± 8.83 | 107.31 ± 14.52 | 107.31 ± 14.52 | 122.58 ± 13.18 | 97.74 ± 18.71 | 95.54 ± 12.73 | 99.10 ± 15.33 | 1.000 | 0.443, 0.655 | 0.245, 0.925 | 2.008, 0.210 |
| Treatment Ⅰ | 114.05 ± 10.35 | 103.95 ± 16.06 | 103.95 ± 16.06 | 104.99 ± 17.10 | 120.38 ± 9.71 | 114.95 ± 16.12 | 88.88 ± 14.60 | |||||
| Treatment Ⅱ | 103.95 ± 15.18 | 95.54 ± 11.97 | 95.54 ± 11.97 | 115.47 ± 9.61 | 108.22 ± 7.05 | 107.51 ± 15.21 | 114.82 ± 8.14 | |||||
| 0.576 | 0.838 | 0.668 | 0.487 | 0.226 | 0.407 | 0.407 | 0.576 | |||||
| COR(ng/mL) | CON | 60.77 ± 2.86 | 57.91 ± 2.71 | 57.55 ± 2.46 | 49.97 ± 2.21 | 48.35 ± 2.02 | 48.22 ± 3.35 | 47.31 ± 1.63 | 1.000 | 30.298, 0.000 | 6.982, 0.026 | 1.976, 0.216 |
| Treatment Ⅰ | 66.61 ± 2.06 | 57.28 ± 2.69 | 56.84 ± 3.42 | 54.01 ± 2.98 | 49.87 ± 2.75 | 53.12 ± 1.86 | 51.92 ± 2.80 | |||||
| Treatment Ⅱ | 66.04 ± 1.65 | 66.39 ± 1.16 | 60.85 ± 1.97 | 60.08 ± 2.25 | 58.90 ± 2.61 | 62.35 ± 2.44 | 62.11 ± 2.42 | |||||
| 0.184 | 0.037 | 0.135 | 0.094 | 0.068 | 0.004 | 0.004 | ||||||
| T3 (nmol/L) | CON | 2.10 ± 0.06 | 2.03 ± 0.09 | 2.03 ± 0.09 | 2.03 ± 0.07 | 2.10 ± 0.02 | 2.33 ± 0.04 | 2.32 ± 0.08 | 1.000 | 18.122, 0.001 | 10.005, 0.012 | 7.338, 0.015 |
| Treatment Ⅰ | 2.18 ± 0.10 | 2.27 ± 0.12 | 2.27 ± 0.11 | 2.23 ± 0.03 | 2.43 ± 0.12 | 2.48 ± 0.10 | 2.50 ± 0.05 | |||||
| Treatment Ⅱ | 2.10 ± 0.05 | 2.33 ± 0.11 | 2.30 ± 0.05 | 2.45 ± 0.05 | 2.80 ± 0.07 | 2.64 ± 0.05 | 2.65 ± 0.11 | |||||
| 0.696 | 0.169 | 0.094 | 0.012 | 0.001 | 0.067 | 0.067 | ||||||
| T4 (nmol/L) | CON | 39.53 ± 3.95 | 45.33 ± 1.14 | 37.18 ± 2.73 | 46.06 ± 3.06 | 45.50 ± 2.50 | 47.47 ± 2.03 | 48.87 ± 2.60 | 0.986 | 44.067, 0.000 | 22.530, 0.002 | 4.302, 0.052 |
| Treatment Ⅰ | 35.04 ± 0.99 | 49.92 ± 1.98 | 43.68 ± 1.78 | 54.38 ± 2.98 | 65.57 ± 2.92 | 60.00 ± 3.69 | 61.21 ± 2.76 | |||||
| Treatment Ⅱ | 43.75 ± 1.89 | 55.53 ± 2.67 | 57.68 ± 2.18 | 62.14 ± 2.34 | 70.55 ± 3.74 | 67.89 ± 3.48 | 68.31 ± 3.60 | |||||
| 0.112 | 0.019 | 0.001 | 0.009 | 0.000 | 0.004 | 0.004 | ||||||
| HSP70(pg/mL) | CON | 120.23 ± 10.10 | 113.37 ± 6.16 | 114.08 ± 7.44 | 128.58 ± 9.50 | 126.99 ± 10.21 | 120.84 ± 6.32 | 120.84 ± 11.17 | 0.976 | 0.182, 0.836 | 3.440, 0.101 | 2.498, 0.148 |
| Treatment Ⅰ | 104.70 ± 5.92 | 123.69 ± 10.86 | 122.65 ± 5.16 | 117.99 ± 3.82 | 113.81 ± 9.97 | 119.84 ± 5.17 | 128.03 ± 8.54 | |||||
| Treatment Ⅱ | 115.08 ± 11.49 | 119.74 ± 9.21 | 121.43 ± 7.42 | 123.20 ± 6.60 | 121.77 ± 7.89 | 118.19 ± 5.56 | 113.04 ± 5.70 | |||||
| 0.523 | 0.722 | 0.815 | 0.733 | 0.526 | 0.508 | 0.508 | ||||||
Note: Global analysis uses repeated measures analysis of variance. p < 0.05 has statistical significance (the same as below).
Effects of astragalus polysaccharides on serum antioxidant indexes of dairy cows.
| Item | Groups | Time(d) | Holistic Analysis (Huynh-Feldt) | Concentration (F, P) | Time (F, P) | Interaction (F, P) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 4 | 7 | 11 | 14 | 18 | 21 | ||||||
| SOD/(U·mL−1) | CON | 48.39 ± 4.50 | 38.10 ± 4.01 | 41.91 ± 9.74 | 46.48 ± 3.30 | 57.78 ± 7.92 | 43.43 ± 10.40 | 43.43 ± 3.46 | 1.000 | 0.468, 0.641 | 0.692, 0.652 | 2.886, 0.115 |
| Treatment Ⅰ | 42.29 ± 7.12 | 56.26 ± 8.97 | 50.79 ± 11.68 | 52.20 ± 3.91 | 45.72 ± 4.14 | 41.15 ± 7.94 | 42.14 ± 5.65 | |||||
| Treatment Ⅱ | 45.84 ± 9.38 | 59.05 ± 11.29 | 50.80 ± 4.77 | 52.32 ± 4.77 | 33.53 ± 7.74 | 52.32 ± 12.67 | 50.11 ± 4.22 | |||||
| 0.738 | 0.231 | 0.602 | 0.709 | 0.092 | 0.737 | 0.737 | ||||||
| MDA/(nmol·mL−1) | CON | 2.27 ± 0.34 | 1.80 ± 0.26 | 3.14 ± 0.37 | 3.90 ± 0.45 | 4.42 ± 0.55 | 3.17 ± 0.38 | 3.31 ± 0.90 | 0.468 | 0.572, 0.584 | 1.239, 0.410 | 1.789, 0.249 |
| Treatment Ⅰ | 2.62 ± 0.50 | 3.02 ± 0.78 | 2.10 ± 0.24 | 3.90 ± 1.10 | 2.56 ± 0.46 | 3.85 ± 0.57 | 6.40 ± 1.07 | |||||
| Treatment Ⅱ | 2.27 ± 0.11 | 2.91 ± 0.31 | 1.98 ± 0.58 | 3.60 ± 0.38 | 2.21 ± 0.23 | 3.13 ± 0.41 | 4.48 ± 0.75 | |||||
| 0.741 | 0.230 | 0.405 | 0.949 | 0.212 | 0.445 | 0.445 | ||||||
| GSH-Px/(U·mL−1) | CON | 545.45 ± 63.03 | 604.36±48.11 | 516.00 ± 41.99 | 583.64 ± 73.78 | 520.37 ± 34.32 | 540.62 ± 38.94 | 507.27 ± 56.17 | 0.647 | 0.922, 0.432 | 9.421, 0.014 | 4.913, 0.039 |
| Treatment Ⅰ | 562.91 ± 79.35 | 569.45 ± 58.56 | 690.55 ± 37.03 | 744.00 ± 66.38 | 502.91 ± 36.58 | 614.02 ± 27.04 | 614.18 ± 45.75 | |||||
| Treatment Ⅱ | 580.36 ± 46.42 | 597.82 ± 60.39 | 524.73 ± 51.42 | 722.18 ± 33.07 | 427.64 ± 29.69 | 563.07 ± 25.91 | 544.36 ± 53.73 | |||||
| 0.930 | 0.897 | 0.065 | 0.182 | 0.793 | 0.768 | 0.768 | ||||||
| LDH/(U·L−1) | CON | 433.75 ± 27.16 | 371.69 ± 16.03 | 428.92 ± 23.69 | 414.16 ± 17.04 | 447.59 ± 24.32 | 491.27 ± 13.66 | 451.55 ± 33.24 | 0.976 | 0.182, 0.836 | 3.440, 0.101 | 2.498, 0.148 |
| Treatment Ⅰ | 334.14 ± 24.26 | 519.28 ± 26.24 | 462.95 ± 22.24 | 515.94 ± 19.17 | 460.64 ± 27.49 | 495.18 ± 15.35 | 465.18 ± 23.45 | |||||
| Treatment Ⅱ | 429.22 ± 25.96 | 433.13 ± 22.48 | 385.84 ± 24.08 | 454.52 ± 9.77 | 446.98 ± 20.90 | 456.02 ± 10.44 | 451.66 ± 16.66 | |||||
| 0.349 | 0.298 | 0.561 | 0.940 | 0.957 | 0.542 | 0.542 | ||||||
Figure 2PCA Scores plot. (A): All-PCA Scores plot, (B): Z vs Q PCA Scores plot, (C): H vs Z PCA Scores plot, (D): H vs Q PCA Scores plot. Q: Pre-test, Z: Mid-test, H: Post-test, QC: quality control.
OPLS-DA model parameter list.
| Groups | N | R2X(cum) | R2Y(cum) | Q2(cum) | R2 | Q2 |
|---|---|---|---|---|---|---|
| Z | 10 | 0.407 | 0.956 | 0.449 | 0.883 | −0.447 |
| H | 10 | 0.312 | 0.985 | 0.609 | 0.934 | −0.298 |
| H | 10 | 0.544 | 0.999 | 0.795 | 0.978 | −0.110 |
Note: The number of principal components in modeling. N: number of samples. R2X (cum): cumulative interpretation rate of the model in the X-axis direction when modeling multivariate statistical analysis. cum: the cumulative result of several principal components. R2Y (cum): cumulative interpretation rate of the model in the Y-axis direction. Q2 (cum): cumulative prediction rate of the model. R2, Q2: The parameters of the response sort test are used to measure whether the model is over-fitting.
Figure 3OPLS-DA scores plots and permutation test plots. (A): Z vs Q PLS-DA Scores plot, (B): H vs Z PLS-DA scores plot, (C): H vs Q PLS-DA scores plot. (D): Z vs Q permutation test plots, (E): H vs Z permutation test plots, (F): H vs Q permutation test plots. Q: Pre-test, Z: Mid-test, H: Post-test.
Figure 4Expression of differential metabolites in serum of dairy cows and Venn diagram. Note: (A–C) were volcanic plots of Z vs Q, H vs Z and H vs Q, respectively. −log10(p-value) is from the original p-value calculated from the differential metabolites. −log10 (0.05) = 1.30 − log10 (p-value) > 1.30 means significant difference. The red dot indicates log2FC > 0, and the metabolite is upregulated. The blue dot indicates log2FC < 0, and the metabolite is downregulated. The gray dot means no significant difference (−log10 (p-value) < 1.3). (D) is the Ven diagram of the difference variables between groups.
Identification and screening of serum differential metabolites of dairy cows.
| Metabolite name | Classification | Retention Time (min) | Quant Mass | Z | H | H vs Q |
|---|---|---|---|---|---|---|
| 2-Picolinic Acid | Organic acid | 6.28 | 136 | ns | ↓↓↓ | ↓ |
| 3-Aminoisobutyric Acid | Organic acid | 9.38 | 102 | ns | ↓↓ | ↓↓↓ |
| Alanine | Amino acid | 7.48 | 116 | ns | ↓ | ↓ |
| Catechol | Amine | 11.4 | 254 | ↓ | ↑ | ns |
| Gamma-Aminobutyric Acid | Organic acid | 9.38 | 102 | ns | ↓↓ | ↓↓↓ |
| Glucose | Carbohydrate | 23.64 | 319 | ns | ns | ↓↓ |
| Glucose-1-Phosphate | Carbohydrate | 17.59 | 274 | ↑ | ns | ns |
| Glutathione | Organic acid | 8.63 | 282 | ↑ | ↑ | ↑↑↑ |
| Glycerol-1-Phosphate | Organic acid | 18.36 | 191 | ns | ns | ↑↑↑ |
| Glycine | Amino acid | 11.18 | 174 | ↑↑ | ns | ↑↑ |
| Lysine | Amino acid | 24.15 | 174 | ↑↑ | ns | ↑↑ |
| Lyxitol | Carbohydrate | 20.11 | 305 | ↓ | ns | ↓ |
| Methylamine | Amine | 15.68 | 176 | ↓ | ↑ | ns |
| Nicotianamine | Alkaloid | 7.54 | 187 | ns | ↓ | ↓ |
| Norvaline | Amino acid | 12.93 | 144 | ns | ↓ | ↓ |
| Phenylacetic Acid | Organic acid | 11.09 | 91 | ↓↓ | ↓↓↓ | ns |
| Pyrophosphate | Inorganic acid | 18.73 | 451 | ns | ↑ | ↑↑↑ |
| Putrescine | Amine | 13.76 | 174 | ↑↑ | ↑ | ↑↑↑ |
| Tryptophan | Amino acid | 28.8 | 202 | ↑↑ | ns | ↑↑↑ |
| Tyrosine | Amino acid | 24.46 | 218 | ↑ | ns | ↑ |
Note: ↑significant upregulation, ↓significant downregulation, ns: not significant, ↑: p < 0.05, ↑↑: p < 0.01, ↑↑↑: p < 0.001.
Figure 5Relative peak area of serum marker metabolites in dairy cows. (A): 2-Picolinic acid. (B): 3-Aminoisobutyric acid. (C): Alanine. (D): Catechol. (E): Gamma-aminobutyric acid. (F): Glucose. G: Glucose-1-phosphate. (H): Glutathione. (I): Glycerol-1-phosphate. (J): Glycine. (K): Lysine. (L): Lyxitol. (M): Methylamine. (N): Nicotianamine. (O): Norvaline. (P): Phenylacetic acid. (Q): Putrescine. (R): Pyrophosphate. (S): Tryptophan. (T): Tyrosine. “&” means Z vs Q significant difference (p < 0.05), “*” means H vs Z significant difference (p < 0.05), “#” means H vs Q significant difference (p < 0.05); “ns” means the difference is not significant (p > 0.05).
Figure 6Heat map of serum differential metabolites in dairy cows. Changes in color represent changes in relative peak area, where red represents increased serum metabolite content and blue represents decreased serum metabolite content.
Figure 7Pathway analysis of metabolites from dairy cows’ serum. Note: −log (p) is from the original p-value calculated from the enrichment analysis. The red line indicates p = 0.01, and the blue line indicates p = 0.05. When the column top is higher than the blue line or the red line, the signal path is significant.
The detailed results of potential metabolic pathways.
| Potential Metabolic Pathway | −log( | Relevant Metabolites |
|---|---|---|
| Protein digestion and absorption | 4.49 | glucose, glycine, tryptophan, tyrosine |
| Glutathione metabolism | 3.34 | glycine, glutathione, putrescine |
| Pentose and glucuronate interconversions | 2.87 | glucose-1-phosphate, lyxitol |
| Glycolysis / Gluconeogenesis | 2.15 | glucose, glucose-1-phosphate |
| Biosynthesis of amino acids | 1.83 | glycine, tryptophan, tyrosine |
Note: −log (p) is from the original p-value calculated from the enrichment analysis.